BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
27.06.24
/
50%
€77.46
Target price
27.06.25
€107.36
Performance (%)
-2.38%
Price
10.07.24
€75.98
Summary
This prediction is currently active. With a performance of -2.38%, the BUY prediction for BioMarin Pharmaceutical Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 27.06.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | 1.280% |
iShares Core DAX® | 1.454% |
iShares Nasdaq 100 | -0.913% |
iShares Nikkei 225® | 2.355% |
iShares S&P 500 | 0.283% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Wells Fargo & Company from $110.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-1.32%
10.07.24
10.07.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-5.40%
10.07.24
10.07.24